Arcutis Biotherapeutics, Inc. (ARQT)
21.22
-1.16
(-5.18%)
USD |
NASDAQ |
Mar 27, 16:00
21.21
-0.01
(-0.05%)
Pre-Market: 20:00
Arcutis Biotherapeutics Total Assets (Quarterly) : 432.97M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.564B |
| ADMA Biologics, Inc. | 633.35M |
| Axsome Therapeutics, Inc. | 689.80M |
| Arcus Biosciences, Inc. | 1.564B |
| Mirum Pharmaceuticals, Inc. | 842.81M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 243.49M |
| Shareholders Equity (Quarterly) | 189.48M |
| Debt to Equity Ratio | 0.6028 |
| Current Ratio | 3.167 |
| Net Debt Paydown Yield | 0.52% |